Australia markets open in 6 hours 53 minutes
  • ALL ORDS

    7,735.80
    -3.50 (-0.05%)
     
  • AUD/USD

    0.7189
    -0.0024 (-0.33%)
     
  • ASX 200

    7,408.80
    -8.50 (-0.11%)
     
  • OIL

    85.09
    +1.27 (+1.52%)
     
  • GOLD

    1,819.80
    +3.30 (+0.18%)
     
  • BTC-AUD

    57,920.47
    -1,636.54 (-2.75%)
     
  • CMC Crypto 200

    993.18
    -16.20 (-1.61%)
     

Cathie Wood's Buying Beam Therapeutics -- Should You?

·4-min read
Cathie Wood's Buying Beam Therapeutics -- Should You?
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Over the past year, shares of Beam Therapeutics (NASDAQ: BEAM) have soared over 174% higher. This is the firm founded and still run by Cathie Wood, one of the world's most famous investors. Beam Therapeutics is pioneering the use of a new base editing technique in the development of new gene therapies.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting